Name: UMIN ID:
Unique ID issued by UMIN | UMIN000008023 |
---|---|
Receipt number | R000009441 |
Scientific Title | Phase II multicenter trial of neoadjuvant chemotherapy followed by radical hysterectomy and adjuvant chemotherapy by irrinotecan hydrochloride and nedaplatin for the patients with stage Ib2-IIb bulky cervical cancer (tumor diameter > 4 cm): OGSK_KCOG-G1201 |
Date of disclosure of the study information | 2012/05/28 |
Last modified on | 2017/05/29 16:39:55 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/05/24 14:55:19 | ||
2 | Update | 2017/05/29 16:39:55 | Last name of lead principal investigator Last name of lead principal investigator Name of primary person or sponsor Organization |